Education
About Us
Working with TipRanks
Follow Us
Aziyo Biologics, Inc. Class A (ELUT)
:ELUT
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 24.75M | $ 23.85M | $ 47.39M | $ 42.68M | $ 42.90M |
| Gross Profit | $ 11.05M | $ 11.64M | $ 19.02M | $ 20.56M | $ 19.77M |
| Operating Income | $ -30.53M | $ -29.99M | $ -23.03M | $ -13.60M | $ -8.41M |
| EBITDA | $ -31.92M | $ -27.46M | $ -15.72M | $ -12.30M | $ -2.63M |
| Net Income | $ -37.66M | $ -32.90M | $ -24.83M | $ -21.82M | $ -11.94M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 19.28M | $ 16.99M | $ 30.43M | $ 39.53M | $ 2.59M |
| Total Assets | $ 43.43M | $ 68.84M | $ 67.17M | $ 82.81M | $ 44.77M |
| Total Debt | $ 23.95M | $ 39.40M | $ 44.99M | $ 52.31M | $ 91.81M |
| Net Debt | $ 4.68M | $ 22.41M | $ 14.56M | $ 12.78M | $ 89.22M |
| Total Liabilities | $ 82.03M | $ 73.87M | $ 53.65M | $ 61.98M | $ 99.88M |
| Stockholders' Equity | $ -38.60M | $ -5.03M | $ 13.52M | $ 20.83M | $ -55.11M |
| Cash Flow | |||||
| Free Cash Flow | $ -22.11M | $ -22.44M | $ -15.99M | $ -14.07M | $ -9.02M |
| Operating Cash Flow | $ -21.76M | $ -21.90M | $ -15.62M | $ -13.44M | $ -8.45M |
| Investing Cash Flow | $ 14.21M | $ -540.00K | $ -369.00K | $ -640.00K | $ -577.00K |
| Financing Cash Flow | $ 9.84M | $ 9.00M | $ 6.88M | $ 51.02M | $ 9.20M |